NetScientific is a transatlantic healthcare IP commercialisation group.
We fund and develop companies that significantly improve the health and well-being of people with chronic diseases.

OUR TEAM

Sector-specialist senior management team with extensive commercial experience.

  • Sir Richard Sykes, FRS

    Sir Richard Sykes, Non-Executive Chairman of the Group, joined NetScientific in 2008. Sir Richard spent thirty years working in the biotechnology and pharmaceutical industries, …

    Chairman
  • Ian Postlethwaite

    Ian Postlethwaite, Chief Executive Office, Chief Financial Officer & Company Secretary, joined NetScientific in June 2016. He brings over 14 years of biopharma experience …

    Chief Executive Officer, Chief Financial Officer & Company Secretary

NEWS

NetScientific plc (“NetScientific” or the “Company”) PDS Biotechnology equity issue and related party transaction   London, UK – 12 February 2020: NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP …

NetScientific plc (“NetScientific” or the “Company”) PDS Biotechnology proposed offering   London, UK – 11 February 2020:  NetScientific plc (AIM: NSCI), the transatlantic healthcare IP commercialisation group, announces …

NetScientific plc (“NetScientific” or the “Company”) Board Change Resignation of Ian Postlethwaite as CEO, CFO and Company Secretary London, UK – 15 January 2020:  NetScientific plc (AIM: NSCI), …

NetScientific healthcare technology group